The CT test is a crucial diagnostic tool for identifying the presence of the Chlamydia trachomatis bacterium. This sexually transmitted infection (STI) often exhibits no symptoms, emphasizing the importance of regular testing. Untreated, CT can lead to severe health complications. Our test provides early detection, allowing prompt intervention and safeguarding your reproductive health. Stay proactive in your well-being with our comprehensive CT testing.
Chlamydia trachomatis is a bacterial infection primarily transmitted through sexual contact. This STI can affect both men and women, potentially leading to serious reproductive health issues if left untreated. Being asymptomatic in many cases, regular testing is vital for early detection and effective management.
The CT test is designed to detect the presence of Chlamydia trachomatis in genital, rectal, or throat samples. By identifying the bacterium’s DNA, the test provides accurate results, enabling timely treatment and preventing the progression of the infection. Early detection through our comprehensive testing is key to maintaining your overall health and well-being.
NAAT is the preferred method for detecting a chlamydia infection. This type of test detects the genetic material (DNA or RNA) of Chlamydia trachomatis. It can be performed using a urine sample or swab of fluid taken from a site of potential infection such as the urethra, vagina, rectum, or eye.
First-void urine (FVU) specimens from men and women, and vaginal, introital or vulvar swabs from women are excellent specimens for the detection of C trachomatis by NAA tests.
A sample of urine is analyzed in the laboratory for presence of this infection. This can be done for males and females. A swab. A sample from the cervix, vagina, throat or anus is collected on a swab for testing.
Chlamydia trachomatis tests are specifically designed to aid in the diagnosis of infections caused by the bacterium Chlamydia trachomatis. These tests detect the presence of Chlamydia trachomatis in bodily fluids such as urine, genital swabs, or throat swabs.
Some NAATs can detect genetic markers associated with antibiotic resistance, providing valuable information for guiding treatment decisions.
Testing should ideally be done 1–2 weeks after potential exposure, as it may take time for the bacteria to multiply and become detectable.